Skip to content

Internet-based Treatment of Stress and Anxiety in Myocardial Infarction With Non-obstructive Coronary Arteries

E-health Treatment of Stress and Anxiety in Stockholm Myocardial Infarction With Non-obstructive Coronaries Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04178434
Acronym
e-SMINC
Enrollment
64
Registered
2019-11-26
Start date
2021-11-11
Completion date
2025-11-30
Last updated
2025-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

Myocardial infarction, Non-obstructive coronary arteries, Takotsubo syndrome

Brief summary

Patient with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome often have high levels of stress and anxiety. At present there are no treatment alternatives in this group of patients. Previously, cognitive behavioral therapy (CBT), primarily aiming at relieving stress, has been shown to decrease morbidity in patient with myocardial infarction with obstructive coronary arteries. The present open randomized study aims to decrease stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome by an internet-based CBT focusing on stress and anxiety.

Interventions

A nine step intervention including internet-based feedback by psychologists

Sponsors

Uppsala University
CollaboratorOTHER
Mid Sweden University
CollaboratorOTHER
Per Tornvall
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50% * age 35-80 years * admission-ECG with sinus rhythm * PSS-14 ≥ 25 and/or HADS-A ≥ 8 during admission * reading and writing proficiency in Swedish * computer/Internet access and literacy

Exclusion criteria

* strong clinical suspicion of myocarditis * spontaneous coronary artery dissection * acute pulmonary embolism * acute myocardial infarction type 2 * cardiomyopathy other than takotsubo syndrome * a previous myocardial infarction due to CAD * expected poor compliance to behavioural therapy * not likely to survive \> one year due to for example cancer

Design outcomes

Primary

MeasureTime frameDescription
Self-rated stress as determined by Perceived Stress Scale 14 (PSS-14)12-14 weeks after the acute eventNormalisation of PSS-14 (\<25 on a scale 0-56 with high numbers indicating increased stress)
Self-rated anxiety as determined by Hospital Anxiety and Depression Scale (HADS)12-14 weeks after the acute eventNormalisation of HADS-A (\<8 on a scale 0-21 with high numbers indicating increased anxiety)

Secondary

MeasureTime frameDescription
Self-rated quality-of-life determined by Research ANd Development-36 (RAND-36)10, 20 and 50 weeks after randomisationRAND-36: 0-100 with high numbers indicating better quality-of-life
Self-rated cardiac anxiety determined by Cardiac Anxiety Questionnaire (CAQ)10, 20 and 50 weeks after randomisationCAQ: 0-72 with high numbers indicating increased cardiac anxiety
Self-rated post-traumatic symptoms determined by Impact of Event Scale-6 (IES-6)10, 20 and 50 weeks after randomisationIES-6: 0-30 with high numbers indicating increased post-traumatic symptoms
Sick leave10, 20 and 50 weeks after randomisationSelf-reported total number of days
Self-rated stress as determined by Perceived Stress Scale 14 (PSS-14)10, 20 and 50 weeks after randomisationPSS-14 (\<25 on a scale 0-56 with high numbers indicating increased stress)
Cortisol in hair10 weeks after randomisationHair cortisol will be determined by RIA-technique in pg/mg
Physiological recovery after stress determined by Heart Rate Variability (HRV)10 weeks after randomisationHRV will be measured by time and frequency domains and by non-linear methods
Physiological recovery after stress determined by salivary cortisol10 weeks after randomisationSalivary cortisol will be determined by RIA-technique in pg/mg
Health-care visits10, 20 and 50 weeks after randomisationSelf-reported total number of visits
Self-rated anxiety as determined by Hospital Anxiety and Depression Scale (HADS)10, 20 and 50 weeks after randomisationHADS-A (\<8 on a scale 0-21 with high numbers indicating increased anxiety)

Countries

Sweden

Contacts

Primary ContactPer Tornvall, MD
per.tornvall@ki.se+46861611000
Backup ContactPatrik Lyngå, RN
patrik.lynga@ki.se

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026